[Federal Register Volume 77, Number 41 (Thursday, March 1, 2012)]
[Notices]
[Page 12650]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4885]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant an Exclusive License

AGENCY: Department of Veterans Affairs, Office of Research and 
Development.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans 
Affairs, Office of Research and Development, intends to grant to 
Somahlution, Inc., 3401 Fiechtner Drive, Fargo, North Dakota 58103, 
USA, an exclusive license to practice the following: U.S. Patent No. 
7,981,596 (Tissue preservation with a salt solution isotonic with 
interstitial fluid) issued July 19, 2011.

DATES: Comments must be received March 16, 2012.

ADDRESSES: Written comments may be submitted through 
www.regulations.gov; by mail or hand-delivery to the Director, 
Regulations Management (02REG), Department of Veterans Affairs, 810 
Vermont Avenue NW., Room 1068, Washington, DC 20420; or by fax to (202) 
273-9026. Copies of comments received will be available for public 
inspection in the Office of Regulation Policy and Management, Room 
1063B, between the hours of 8 a.m. and 4:30 p.m., Monday through Friday 
(except holidays). Call (202) 461-4902 for an appointment (This is not 
a toll-free number). In addition, during the comment period, comments 
may be viewed online through the Federal Docket Management System at 
http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Amy E., Centanni, Director of 
Technology Transfer, Office of Research and Development (10P9TT), 
Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 
20420, (202) 443-5640 (This is not a toll-free number). Copies of the 
published patent applications may be obtained from the U.S. Patent and 
Trademark Office at www.uspto.gov.

SUPPLEMENTARY INFORMATION: It is in the public interest to so license 
these inventions, as Somahlution, Inc., submitted a complete and 
sufficient application for a license. The prospective exclusive license 
will be royalty-bearing and will comply with the terms and conditions 
of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license 
may be granted unless, within 15 days from the date of this published 
Notice, the Department of Veterans Affairs Office of Research and 
Development receives written evidence and argument which establishes 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.

    Dated: February 23, 2012.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2012-4885 Filed 2-29-12; 8:45 am]
BILLING CODE 8320-01-P